|
Prof. Dr. Lokman VARIŞLI
|
|
|
Eğitim
|
|
|
Lisans: Harran
Üniversitesi, Fen Edebiyat Fakültesi, Biyoloji Bölümü – 2001
|
|
|
Yüksek Lisans: Harran Üniversitesi, Fen Bilimleri Enstitüsü, Biyoloji
Anabilim Dalı – 2005
|
|
|
Doktora: Ege
Üniversitesi, Fen Bilimleri Enstitüsü, Biyomühendislik Anabilim Dalı – 2012
|
|
İlgi Alanları
|
|
|
Kanser Biyolojisi
Hücre İçi Sinyal İletim Mekanizmaları
|
|
|
|
Adres: Dicle Üniversitesi Fen Fakültesi Moleküler Biyoloji
ve Genetik Bölümü 21280 Sur-Diyarbakır
|
|
E-Mail: lokman.varisli@dicle.edu.tr
|
|
Tel (Lab): 3249
|
|
 
|
|
Seçilmiş Yayınlar
|
|
Varisli L, Cen O, Vlahopoulos S.
Dissecting pharmacological effects of chloroquine in cancer treatment:
interference with inflammatory signaling pathways. Immunology.
2020;159(3):257-278. doi:10.1111/imm.13160
|
|
Egea J, Fabregat I, Frapart YM, et al.
European contribution to the study of ROS: A summary of the findings and
prospects for the future from the COST action BM1203 (EU-ROS) [published
correction appears in Redox Biol. 2018 Apr;14: 694- 696]. Redox Biol.
2017; 13: 94- 162. doi:10.1016/j.redox.2017.05.007
|
|
Varisli L, Ozturk BE, Akyuz GK,
Korkmaz KS. HN1 negatively influences the β-catenin/E-cadherin interaction,
and contributes to migration in prostate cells. J Cell Biochem.
2015;116(1):170-178. doi:10.1002/jcb.24956
|
|
Sertkaya S, Hamid SM, Dilsiz N,
Varisli L. Decreased expression of EFS is correlated with the advanced
prostate cancer. Tumour Biol. 2015;36(2):799-805. doi:10.1007/s13277-014-2703-5
|
|
Hamid SM, Cicek S, Karamil S, et al.
HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate. Mol
Cell Endocrinol. 2014;383(1-2):38-47. doi:10.1016/j.mce.2013.12.003
|
|
Debelec-Butuner B, Alapinar C, Varisli
L, et al. Inflammation-mediated abrogation of androgen signaling: an in vitro
model of prostate cell inflammation. Mol Carcinog.
2014;53(2):85-97. doi:10.1002/mc.21948
|
|
Varisli L. Identification of new genes downregulated in
prostate cancer and investigation of their effects on prognosis. Genet
Test Mol Biomarkers. 2013;17(7):562-566. doi:10.1089/gtmb.2012.0524
|
|
Erbaykent-Tepedelen B, Ozmen B,
Varisli L, et al. NKX3.1 contributes to S phase entry and regulates DNA
damage response (DDR) in prostate cancer cell lines. Biochem Biophys
Res Commun. 2011;414(1):123-128. doi:10.1016/j.bbrc.2011.09.035
|
|
Varisli L, Gonen-Korkmaz C, Syed HM,
et al. Androgen regulated HN1 leads proteosomal degradation of androgen
receptor (AR) and negatively influences AR mediated transactivation in
prostate cells. Mol Cell Endocrinol. 2012;350(1):107-117.
doi:10.1016/j.mce.2011.11.027
|
|
Varisli L, Gonen-Korkmaz C,
Debelec-Butuner B, et al. Ubiquitously expressed hematological and
neurological expressed 1 downregulates Akt-mediated GSK3β signaling, and its
knockdown results in deregulated G2/M transition in prostate cells. DNA
Cell Biol. 2011;30(6):419-429. doi:10.1089/dna.2010.1128
|